EP 0633781 A4 19950419 - COMPOSITIONS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERTROPHY.
Title (en)
COMPOSITIONS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERTROPHY.
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG DER BENIGNEN PROSTATAHYPERTROPIE.
Title (fr)
COMPOSITIONS ET PROCEDES PERMETTANT DE TRAITER L'HYPERTROPHIE PROSTATIQUE BENIGNE.
Publication
Application
Priority
- US 9303145 W 19930402
- US 86211792 A 19920402
- US 99779292 A 19921229
Abstract (en)
[origin: WO9319758A1] Invented are pharmaceutical compositions containing N-t-butyl-androst-3,5-diene-17 beta -carboxamide)-3-carboxylic acid or a salt thereof or 17 beta -(N-t-butylcarboxamide-estra-1,3,5(10)-triene-3-carboxylic acid or a salt thereof and an alpha-adrenergic receptor antagonist compound, and methods of using these compositions to treat benign prostatic hypertrophy.
IPC 1-7
IPC 8 full level
A61K 31/205 (2006.01); A61K 31/475 (2006.01); A61K 31/505 (2006.01); A61K 31/56 (2006.01); A61K 45/06 (2006.01); A61P 13/02 (2006.01); A61P 15/00 (2006.01)
CPC (source: EP KR)
A61K 31/56 (2013.01 - EP KR); A61P 13/02 (2017.12 - EP); A61P 15/00 (2017.12 - EP)
Citation (search report)
- [XP] WO 9216213 A1 19921001 - MERCK & CO INC [US]
- See references of WO 9319758A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9319758 A1 19931014; AU 3945193 A 19931108; AU 668157 B2 19960426; CA 2133440 A1 19931014; EP 0633781 A1 19950118; EP 0633781 A4 19950419; JP H07505398 A 19950615; KR 950700746 A 19950220; MX 9301939 A 19940831; NZ 251658 A 19960827
DOCDB simple family (application)
US 9303145 W 19930402; AU 3945193 A 19930402; CA 2133440 A 19930402; EP 93908738 A 19930402; JP 51774193 A 19930402; KR 19940703522 A 19941004; MX 9301939 A 19930402; NZ 25165893 A 19930402